Sienna Biopharmaceuticals' Incubator/Accelerator Round

Sienna Biopharmaceuticals raised a round of funding on May 06, 2013. Investors include JLabs.

Sienna Biopharmaceuticals (NASDAQ: SNNA) is a medical dermatology and aesthetics company focused on developing safe and effective targeted therapies to treat inflammatory skin conditions and aesthetic…

Articles about Sienna Biopharmaceuticals' Incubator/Accelerator Round: